Bret Stephens’ Pharmapologetics
Now, when the demand for both innovation and access is high, it’s time to think outside the box and reevaluate the relationship between pharmaceutical drugs and the patent system. Perhaps a prize system is in order, or maybe a formal guarantee from firms receiving BARDA grants that the drugs will not be patented.Featured Publications
Toward Clarity and Consensus on “E”SG
ITC Policy Project Series: Record-Breaking Year at the ITC (for NPEs)
Spotlight on Criminal Justice: National Criminal Justice Month – March
The United States is at a Tipping Point on Juvenile Life Without Parole
Considerations for Florida’s 2023 Privacy Journey